These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35778257)

  • 21. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
    Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
    Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
    Baass A; Wassef H; Tremblay M; Bernier L; Dufour R; Davignon J
    Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
    Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review.
    Shoji K; Morita H; Ishigaki Y; Rivard CJ; Takayasu M; Nakayama K; Nakayama T; Inoue Y; Ayaki M; Yoshimura A
    Clin Nephrol; 2011 Oct; 76(4):323-8. PubMed ID: 21955868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux.
    Anthanont P; Asztalos BF; Polisecki E; Zachariah B; Schaefer EJ
    J Clin Lipidol; 2015; 9(3):390-5. PubMed ID: 26073399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
    Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel missense mutation (Asn5-->Ile) in lecithin: cholesterol acyltransferase (LCAT) gene in a Japanese patient with LCAT deficiency.
    Okubo M; Aoyama Y; Shio H; Albers JJ; Murase T
    Int J Clin Lab Res; 1996; 26(4):250-4. PubMed ID: 9007616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique genetic and biochemical presentation of fish-eye disease.
    Kuivenhoven JA; van Voorst tot Voorst EJ; Wiebusch H; Marcovina SM; Funke H; Assmann G; Pritchard PH; Kastelein JJ
    J Clin Invest; 1995 Dec; 96(6):2783-91. PubMed ID: 8675648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ocular manifestation in LCAT deficiency--a clinicopathological correlation].
    Viestenz A; Seitz B
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):499-502. PubMed ID: 12886512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two novel frame shift mutations in lecithin:cholesterol acyltransferase (LCAT) gene associated with a familial LCAT deficiency phenotype.
    Park CW; Lim MH; Youn DY; Jung SE; Chung S; Ahn YS; Chang YS; Lee JH
    Atherosclerosis; 2009 Oct; 206(2):346-8. PubMed ID: 19329119
    [No Abstract]   [Full Text] [Related]  

  • 34. Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family.
    Idzior-Waluś B; Sieradzki J; Kostner G; Małecki MT; Klupa T; Wesołowska T; Rostworowski W; Hartwich J; Waluś M; Kieć AD; Naruszewicz M
    Atherosclerosis; 2006 Apr; 185(2):413-20. PubMed ID: 16051254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83-->stop) and LCAT (tyr156-->asn).
    Klein HG; Lohse P; Duverger N; Albers JJ; Rader DJ; Zech LA; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 1993 Jan; 34(1):49-58. PubMed ID: 8445342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.
    Huang W; Sasaki J; Matsunaga A; Nanimatsu H; Moriyama K; Han H; Kugi M; Koga T; Yamaguchi K; Arakawa K
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):389-96. PubMed ID: 9514407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
    Cho KH; Durbin DM; Jonas A
    J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment.
    Naito S; Kamata M; Furuya M; Hayashi M; Kuroda M; Bujo H; Kamata K
    Atherosclerosis; 2013 May; 228(1):193-7. PubMed ID: 23522979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
    Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI
    J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.